Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 4, 2002, Pages 1047-1057

  Firat, Selim ^a   Bousamra, Michael ^a   Gore, Elizabeth ^a   Byhardt, Roger W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Comorbidity; Non small cell lung cancer; Performance status; Stage I

Indexed keywords

HISTOLOGY; RADIOTHERAPY; TOBACCO;

COMORBIDITY;

TUMORS;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SQUAMOUS CELL; TOBACCO; TUMOR VOLUME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0037086065     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02741-9     Document Type: Article

References (37)

1. Incidence of local recurrence and second primary tumors in resected stage I lung cancer
2. Stage I nonsmall cell lung cancer: A multivariate analysis of treatment methods and patterns of recurrence
3. Diameter, cell type, and survival in stage I primary non-small cell lung cancer
4. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small cell lung cancer?
5. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer
6. Limited resection for stage I lung cancer
7. Modality of failure following resection of stage I and stage II non-small cell lung cancer
8. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: A prospective randomized study
9. Stage I non-small cell cancer of the lung: Results of surgical resection at Fairfax Hospital
10. Radiation therapy alone for stage I non-small cell lung cancer
11. Radiotherapy alone for medically inoperable stage I non-small cell lung cancer: The Duke experience
12. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer
13. Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?
14. Results of radical radiation therapy in clinical stage I technically operable non-small cell lung cancer
15. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: A retrospective analysis of 149 patients
16. Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer
17. Curative radiotherapy for technically operable stage I nonsmall cell lung cancer
18. Cumulative illness rating scale
19. A new method of classifying prognostic comorbidity in longitidunal studies: Development and validation
20. Comorbidity and functional status are independent in older cancer patients
21. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices
22. A prospective evaluation of the cumulative illness scale
23. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Scale
24. Clinical Severity Staging System for oropharyngeal cancer
25. Clinical symptoms and comorbidity: Significance for the prognostic classification of cancer
26. Cancer of the larynx
27. Comorbid and clinical determinants of prognosis in endometrial cancer
28. A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancer
29. New clinical severity staging system for cancer of the larynx
30. A clinical-severity staging system for patients with lung cancer
31. The effect of comorbidity on 3-year survival of women with primary breast cancer
32. Validation of the Charlson Comorbidity Index in patients with head and neck cancer: A multi-institutional study
33. Validation of a measure of physical illness burden at autopsy: The Cumulative Illness Rating Scale
34. Nonanatomic prognostic factors in carcinoma of the lung
35. Survival in early-stage non-small cell lung cancer
36. Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone